SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-158200
Filing Date
2009-07-29
Accepted
2009-07-29 16:35:29
Documents
6
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 VIROPHARMA INCORPORATED d10q.htm 10-Q 511161
2 INTERMEDIATE SUPPLY AGREEMENT WITH BIOTEST AG dex104.htm EX-10.4 77007
3 AMENDMENT TO DISTRIBUTION AND MANUFACTURING SERVICES AGREEMENT dex105.htm EX-10.5 22366
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9206
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9196
6 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 3750
  Complete submission text file 0001193125-09-158200.txt   634056
Mailing Address 397 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 397 EAGLEVIEW BLVD EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

IRS No.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21699 | Film No.: 09970598
SIC: 2834 Pharmaceutical Preparations